Mirae Asset Global Etfs Holdings Ltd. Design Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,270 shares of DSGN stock, worth $91,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,270Holding current value
$91,762% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DSGN
# of Institutions
98Shares Held
31.9MCall Options Held
1.1KPut Options Held
21.3K-
Sr One Capital Management, LP6.53MShares$36.8 Million9.6% of portfolio
-
Logos Global Management LP San Francisco, CA5.03MShares$28.4 Million1.58% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$13 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.7MShares$9.56 Million0.08% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$8.35 Million0.61% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $315M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...